FDA clears MSD’s Keytruda combo plus Welireg for ccRCC treatment

MSD has received approval from the FDA for both Keytruda and Keytruda Qlex, in combination with Welireg, as an adjuvant treatment for adults with renal ccRCC. The post FDA clears MSD’s Keytruda combo plus Welireg for ccRCC treatment appeared first on Hospital Management .